Achieve Life Sciences (ACHV) Tops Q4 EPS by 21c

Achieve Life Sciences (NASDAQ: ACHV) reported Q4 EPS of ($0.83), $0.21 better than the analyst estimate of ($1.04).

For earnings history and earnings-related data on Achieve Life Sciences (ACHV) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Aspire Biopharma to acquire automotive supplier for $30 million
• United Community Banks sells equipment finance unit for $1.9 billion